Ryan Crandall - 15 Oct 2026 Form 4 Insider Report for MARIMED INC. (MRMD)

Reporting relationship: Chief Commercial Officer
Issuer ticker: MRMD
Reported as of: 15 Oct 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Oct 2026, 18:49:47 UTC
Prior SEC filing: 28 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ Ryan Crandall

Filing notes and source

Key filing fact

Ryan Crandall filed Form 4 for MARIMED INC. (MRMD) on 15 Oct 2026.

Key facts

This page summarizes Ryan Crandall's Form 4 filing for MARIMED INC. (MRMD).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 15 Oct 2026, 18:49.

Change

Previous filing in this sequence was filed on 28 Sep 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002062820 Primary reporting owner

Crandall Ryan

Relationship: Chief Commercial Officer
Address: C/O MARIMED INC., 10 OCEANA WAY, NORWOOD
Signature: /s/ Ryan Crandall
Signature date: 15 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MRMD transaction

Common stock

Options Exercise

Transaction value
Shares: +32,812
Change %: +2.9%
Price: $0.000000^*
Shares after: 1,161,009
Date: 15 Oct 2026
Ownership: Direct
Footnotes: F1

MRMD transaction

Common stock

Tax liability

Transaction value
Shares: -9,631
Change %: -0.83%
Price: $0.0600^*
Shares after: 1,151,378
Date: 15 Oct 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MRMD transaction Derivative

Restricted Stock Units (RSU)

Options Exercise

Transaction value
Shares: -32,812
Change %: -33%
Price: $0.000000^*
Shares after: 65,625
Date: 15 Oct 2026
Ownership: Direct
Underlying class: Common Stock, par value $.001 per share
Underlying amount: 32,812
Exercise price
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

RSUs convert to shares of common stock on a one-for-one basis.

Footnote F2

Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.

Footnote F3

The RSUs were granted on April 15, 2026; the remaining RSUs under this grant will vest as follows: 32,813 on January 15, 2027 and 32,812 on April 15, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.